Authors: BEHOUNEK BD MARKOWITZ JS BERGMAN M MCGOVERN ME KASSLERTAUB KB VANHANEN H ELORANTA M JUVONEN J KANTOLA I KEKKI S KIVELA H KNUTAR F NISSEN M SALMI J SALONEN R TARPILA S TUNTURIHIHNALA H AMANN FW BERENDES G BONNER G DUBACH UC EGGSTEIN M FRANKENBERG HV FROER KL HOHL H HOPPE F KUMMER H MARZ W MOCCETTI T NOSEDA G REUTTER FW SCHWENKE R VOSSCHULTE G WAMBACH G WEIDMANN P BONNIER JJRM DEWEERD P HUIGE MC JANSEN LJ TERIJDT AJ TEVELDE K OLSSON AG LARSSON H ASPLUND J DAHLQVIST A LONNQVIST F FRITHZ G HOGLUND C KJELLSTROM T KUYLENSTIERNA J MOLLER B OSTERGREN J CRAMB R DAVIES J",IVERSON,"JOHNSTON GD MUNRO A PEACOCK I RITCHIE LD RITTER J RYLANCE PB SEVER PS SIMMONS RL

Citation: Bd. Behounek et al., EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS, The American journal of cardiology, 72(14), 1993, pp. 1031-1037